Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention

Importance to implementation of the 2013 ACC/AHA guidelines

Seth Martin, Laurence S. Sperling, Michael Blaha, Peter W F Wilson, Ty J. Gluckman, Roger S Blumenthal, Neil J. Stone

Research output: Contribution to journalArticle

Abstract

Successful implementation of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines hinges on a clear understanding of the clinician-patient risk discussion (CPRD). This is a dialogue between the clinician and patient about potential for atherosclerotic cardiovascular disease risk reduction benefits, adverse effects, drug-drug interactions, and patient preferences. Designed especially for primary prevention patients, this process of shared decision making establishes the appropriateness of a statin for a specific patient. CPRD respects the autonomy of an individual striving to make an informedchoice aligned with personal values and preferences. Dedicating sufficient timeto high-quality CPRD offers an opportunity to strengthen clinician-patient relationships, patient engagement, and medication adherence. We review the guideline-recommended CPRD, the general concept of shared decision making and decision aids, the American College of Cardiology/American Heart Association Risk Estimator application as an implementation tool, and address potential barriers to implementation.

Original languageEnglish (US)
Pages (from-to)1361-1368
Number of pages8
JournalJournal of the American College of Cardiology
Volume65
Issue number13
DOIs
StatePublished - 2015

Fingerprint

Cardiovascular Diseases
Guidelines
Decision Making
Patient Participation
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Medication Adherence
Decision Support Techniques
Patient Preference
Risk Reduction Behavior
Primary Prevention
Patient Compliance
Drug Interactions
Cholesterol
Pharmaceutical Preparations

Keywords

  • Cerebrovascular disease
  • Coronary heart disease
  • Lipid-lowering therapy
  • Myocardial infarction
  • Risk estimation
  • Shared decision making

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention : Importance to implementation of the 2013 ACC/AHA guidelines. / Martin, Seth; Sperling, Laurence S.; Blaha, Michael; Wilson, Peter W F; Gluckman, Ty J.; Blumenthal, Roger S; Stone, Neil J.

In: Journal of the American College of Cardiology, Vol. 65, No. 13, 2015, p. 1361-1368.

Research output: Contribution to journalArticle

@article{d2170bb6166f4d65bd601d3f0d3ee542,
title = "Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: Importance to implementation of the 2013 ACC/AHA guidelines",
abstract = "Successful implementation of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines hinges on a clear understanding of the clinician-patient risk discussion (CPRD). This is a dialogue between the clinician and patient about potential for atherosclerotic cardiovascular disease risk reduction benefits, adverse effects, drug-drug interactions, and patient preferences. Designed especially for primary prevention patients, this process of shared decision making establishes the appropriateness of a statin for a specific patient. CPRD respects the autonomy of an individual striving to make an informedchoice aligned with personal values and preferences. Dedicating sufficient timeto high-quality CPRD offers an opportunity to strengthen clinician-patient relationships, patient engagement, and medication adherence. We review the guideline-recommended CPRD, the general concept of shared decision making and decision aids, the American College of Cardiology/American Heart Association Risk Estimator application as an implementation tool, and address potential barriers to implementation.",
keywords = "Cerebrovascular disease, Coronary heart disease, Lipid-lowering therapy, Myocardial infarction, Risk estimation, Shared decision making",
author = "Seth Martin and Sperling, {Laurence S.} and Michael Blaha and Wilson, {Peter W F} and Gluckman, {Ty J.} and Blumenthal, {Roger S} and Stone, {Neil J.}",
year = "2015",
doi = "10.1016/j.jacc.2015.01.043",
language = "English (US)",
volume = "65",
pages = "1361--1368",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "13",

}

TY - JOUR

T1 - Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention

T2 - Importance to implementation of the 2013 ACC/AHA guidelines

AU - Martin, Seth

AU - Sperling, Laurence S.

AU - Blaha, Michael

AU - Wilson, Peter W F

AU - Gluckman, Ty J.

AU - Blumenthal, Roger S

AU - Stone, Neil J.

PY - 2015

Y1 - 2015

N2 - Successful implementation of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines hinges on a clear understanding of the clinician-patient risk discussion (CPRD). This is a dialogue between the clinician and patient about potential for atherosclerotic cardiovascular disease risk reduction benefits, adverse effects, drug-drug interactions, and patient preferences. Designed especially for primary prevention patients, this process of shared decision making establishes the appropriateness of a statin for a specific patient. CPRD respects the autonomy of an individual striving to make an informedchoice aligned with personal values and preferences. Dedicating sufficient timeto high-quality CPRD offers an opportunity to strengthen clinician-patient relationships, patient engagement, and medication adherence. We review the guideline-recommended CPRD, the general concept of shared decision making and decision aids, the American College of Cardiology/American Heart Association Risk Estimator application as an implementation tool, and address potential barriers to implementation.

AB - Successful implementation of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines hinges on a clear understanding of the clinician-patient risk discussion (CPRD). This is a dialogue between the clinician and patient about potential for atherosclerotic cardiovascular disease risk reduction benefits, adverse effects, drug-drug interactions, and patient preferences. Designed especially for primary prevention patients, this process of shared decision making establishes the appropriateness of a statin for a specific patient. CPRD respects the autonomy of an individual striving to make an informedchoice aligned with personal values and preferences. Dedicating sufficient timeto high-quality CPRD offers an opportunity to strengthen clinician-patient relationships, patient engagement, and medication adherence. We review the guideline-recommended CPRD, the general concept of shared decision making and decision aids, the American College of Cardiology/American Heart Association Risk Estimator application as an implementation tool, and address potential barriers to implementation.

KW - Cerebrovascular disease

KW - Coronary heart disease

KW - Lipid-lowering therapy

KW - Myocardial infarction

KW - Risk estimation

KW - Shared decision making

UR - http://www.scopus.com/inward/record.url?scp=84933073547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933073547&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2015.01.043

DO - 10.1016/j.jacc.2015.01.043

M3 - Article

VL - 65

SP - 1361

EP - 1368

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 13

ER -